Two ZS Pharma Execs Picked for Allakos Management Team

Xconomy San Francisco — 

Robert Alexander has been named CEO of San Carlos, CA, drug developer Allakos. Alexander most recently served as CEO of Coppell, TX-based ZS Pharma, a subsidiary of AstraZeneca (NYSE: AZN). Before joining ZS Pharma, Alexander was a director at Alta Partners, a venture capital firm. Allakos is developing therapeutic antibody drugs to treat allergic and inflammatory diseases.

Allakos also announced that Adam Tomasi has been hired as chief operating officer and chief financial officer. Tomasi was previously chief scientific officer and head of corporate development at ZS Pharma.